Annual BioPolicy Summit on Research Reproducibility in Washington, DC, February 9th

Home / Community Blog / Annual BioPolicy Summit on Research Reproducibility in Washington, DC, February 9th

Community Blog

Annual BioPolicy Summit on Research Reproducibility in Washington, DC, February 9th

Contributor: Sherry Ward, AltTox

Source: GBSI Media Alert

New Reproducibility2020 initiative will provide framework for action

On Tuesday, February 9, at 12:00 noon EST, Global Biological Standards Institute (GBSI) will host its 2016 BioPolicy Summit at the Newseum in Washington, DC. The Summit welcomes premiere life science thought leaders as speakers, panelists, and guests who will focus on the complex causes of irreproducibility and offer tangible solutions to drive greater research quality and accelerate the discovery of life-saving therapies.

The Summit will also introduce GBSI’s Reproducibility2020, an action plan for the biomedical research community to significantly improve the quality of research by 2020 targeting: 1) improved validation and standardization of biological reagents; 2) better tools and technologies to expand open access for reporting and sharing protocols and data; and 3) increased training that emphasizes rigorous study design and practice.

Panelists will identify calls-to-action for attendees to implement in their own areas of expertise to bring about change in the development of biomedical research standards and best practices. A question and answer session will provide attendees the opportunity to further probe the insights and contributions of presenters and offer their own perspective.

Advances in life science research are based on the quality, reproducibility and translatability of published data and findings. Yet irreproducibility in preclinical research is pervasive and contributes to delays and costs in therapeutic drug development and failed clinical trials as well as reduced trust in the biomedical research process. There are a variety of reasons for irreproducibility. Solutions will lead to more cost-effective research and accelerate the discovery of diagnostics and treatments that can save lives.

Media are invited to attend the Summit.

A live webcast will be available for those who would like to participate remotely.  


Keynote presenter:  Judith Kimble, PhD, Vilas Professor of Biochemistry, Molecular Biology, Medical Genetics and Cell and Regenerative Biology at the University of Wisconsin–Madison; Investigator, Howard Hughes Medical Institute

Panel moderator:  Richard Harris, award-winning journalist and Senior Science Correspondent, National Public Radio (on sabbatical), and featuring:

  • Arturo Casadevall, MD, PhD, Bloomberg Distinguished Professor, Alfred and Jill Sommer Professor and Chair, Professor, Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health
  • Amy Herr, PhD, Lester John & Lynne Dewar Lloyd Distinguished Professor, Department of Bioengineering at the University of California, Berkeley
  • Joshua LaBaer, MD, PhD, Director, Virginia G. Piper Center for Personalized Diagnostics, Virginia G. Piper Chair of Personal Medicine, Professor of Chemistry and Biochemistry, The BioDesign Institute at Arizona State University
  • Brian Nosek, PhD, Professor, Department of Psychology at the University of Virginia; Executive Director of the Center for Open Science
  • Timothy Simcoe, PhD, Associate Professor of Strategy & Innovation, Questrom School of Business at Boston University

About Global Biological Standards Institute (GBSI)

GBSI, a non-profit organization, is dedicated to enhancing the quality of biomedical research by advocating best practices and standards to accelerate the translation of research breakthroughs into life-saving therapies. For more information, visit; Twitter @GBSIorg.

Related AltTox Content

May 29, 2015 In the Spotlight: “Are we inseparable? Reproducible bioassays and authenticated cell lines: New initiatives by the Global Biological Standards Institute”